Vernal Biosciences, a manufacturer of high purity mRNA for research and clinical use, announced the closing of a seed round of financing.

Alloy Therapeutics led the round and was joined by the Vermont Center for Emerging Technologies and individual angel investors.

Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis. The company is experienced at overcoming the bottlenecks involved in mRNA-based R&D with reliable, high-purity manufacturing, and an approach rooted in a quality-first culture and deep regulatory experience.